✦ LIBER ✦

Eastman, Avantium extend R&D deal

Publisher: Elsevier Science
Year: 2003
Weight: 33 KB
Volume: 2003
Category: Article
ISSN: 1351-4180
DOI: 10.1016/s1351-4180(03)00816-x

No coin nor oath required. For personal study only.

✦ Synopsis

development and production of pharmaceutical intermediates. AHF integrates the introduction of versatile aldehyde functionality with the formation of a chiral centre. Dow's new generation of chiral bisphosphite ligands is claimed to expand the scope of the technology beyond the vinylarene substrates.

📜 SIMILAR VOLUMES

Avantium and ABB Lummus extend catalyst

Avantium and ABB Lummus extend catalyst R&D

📂 Article 📅 2003 🏛 Elsevier Science ⚖ 32 KB

Avantium ups R&D

📂 Article 📅 2007 🏛 Elsevier Science ⚖ 425 KB

Avantium doubles R&D capacity

📂 Article 📅 2007 🏛 Elsevier Science ⚖ 424 KB

## Avantium doubles R&D capacity Avantium Technologies, a private Dutch research firm, will increase twofold

Cargill/Codexis sign R&D deal

📂 Article 📅 2003 🏛 Elsevier Science ⚖ 31 KB

Avantium doubles R&D capacity to accommo

Avantium doubles R&D capacity to accommodate strong business growth

📂 Article 📅 2007 🏛 Elsevier Science ⚖ 442 KB

Verenium and BP extend Galaxy joint R&D

Verenium and BP extend Galaxy joint R&D programme

📂 Article 📅 2010 🏛 Elsevier Science ⚖ 62 KB

doubled to over 4 bn l/y. Also included in the jv are Iogen, a Canadian firm attempting to produce ethanol from straw, and Codexis, an enzyme producer. Because second-generation biofuels could take up to ten years to commercialize, in 2009 Shell sold its stake in Choren, a German producer of such bi